What is Brightseed?
Founded in 2017, Brightseed operates at the vanguard of the digital biology revolution. By leveraging advanced machine learning to analyze the molecular structure of plants, the company identifies hidden health benefits that were previously inaccessible to traditional research methods. This data-driven approach allows Brightseed to partner with global food and wellness enterprises, providing them with actionable insights to develop healthier, more effective products. The company's market position is defined by its unique ability to bridge the gap between complex botanical data and scalable consumer health solutions, effectively transforming how the industry approaches nutrition and preventative wellness.
How much funding has Brightseed raised?
Brightseed has raised a total of $95M across 2 funding rounds:
Series A
$27M
Series B
$68M
Series A (2020): $27M with participation from Horizons Ventures, Lewis & Clark AgriFood Fund II, CGC Ventures, and Seed 2 Growth Ventures
Series B (2022): $68M led by Temasek
Key Investors in Brightseed
Temasek
A global investment company headquartered in Singapore that acts as a generational investor, focusing on long-term value creation and sustainable growth across diverse sectors.
Horizons Ventures
A venture capital firm specializing in deep science and technology, dedicated to supporting transformative projects that aim to improve the future of humanity.
Lewis & Clark AgriFood Fund II
A growth equity-focused investment fund specializing in the AgriFood sector, leveraging deep scientific expertise and geographic proximity to agricultural production to drive value in tech-enabled companies.
What's next for Brightseed?
With the infusion of recent capital, Brightseed is well-positioned to accelerate its commercialization efforts and expand its Forager platform's capabilities. The strategic focus will likely shift toward scaling partnerships with major CPG (Consumer Packaged Goods) entities and deepening its clinical validation pipeline. As the company transitions from a research-heavy development phase to a growth-oriented commercial entity, the focus will remain on securing regulatory approvals and integrating its bioactive discoveries into mainstream supply chains. This expansion phase is critical for establishing Brightseed as the definitive data layer for the future of functional nutrition and sustainable health innovation.
See full Brightseed company page
